JENNIFER CHAIRGE: Open Payments
NPI 1760136147 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 32 payments from 8 companies in 2025. Trend: 2023 $272 · 2024 $1,183 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $245 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Alkermes, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, SPRAVATO, FANAPT, Auvelity, HETLIOZ.
Industry payments across PA — which companies pay providers there.
